Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the Literature

por Delacruz, Wilfred, Setlik, Robert, Hassantoufighi, Arash, Daya, Shyam, Cooper, Susannah, Selby, Dale, Brown, Alexander
Publicado 2016